New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab

Hidradenitis suppurativa Research

Author(s): Acquacalda E, Roux CH, Albert C, Breuil V, Passeron T, Euller-Ziegler L

OBJECTIVES: Severe hidradenitis suppurativa (HS), under infliximab, can be associated with different forms of arthritis whose mechanism is unclear. Our objective is to establish the frequency and clinical presentation of new-onset arthritis in HS under infliximab.

METHODS: Severe HS patients under infliximab were followed up between 2007-2012. New articular inflammatory manifestations were investigated by rheumatologist.

RESULTS: Three patients over eleven developed a polyarthritis. Mean duration of arthritis was 3 months. At treatment’s stop: 2 patients improved and 1 relieved with adalimumab.

CONCLUSION: The inflammatory rheumatism’s frequency in HS under infliximab seems underestimated.

Dermatology Journal and/or Publisher

Journal Name: Joint, bone, spine : revue du rhumatisme
Journal Abbreviation: Joint Bone Spine
Journal Date Published: 2015-10-10

National Center for Biotechnology Information

PMID: 25776450
Article Source:
Lasted Revision: 2015-10-10

Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).


Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2018  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?